Study Details: The data used by the researchers was sourced from TriNetX, a large database with information on approximately 127 million patients from 15 countries, predominantly the United States
This research points to a role for Akkermansia in gut-barrier and metabolic health generally
Results from the ACHIEVE-1 trial showed that orforglipron led to robust efficacy outcomes across multiple endpoints: Weight Loss Observed: Orforglipron doses of 3 mg, 12 mg, and 36 mg were tested, with the highest dose (36 mg) resulting in the greatest weight loss
Whether that's worth the wait, the cost, and the uncertainty of using an unapproved drug depends on your situation
Both medications support weight loss and improve cholesterol, but tirzepatide often produces stronger reductions in LDL and triglycerides because it targets two hormone pathways instead of one